Product Highlight - Moxifloxacin (Floxsafe/Floxsafe IV)

FLOXSAFE ensures fast recovery because of:

• Minimal side effects & risk of relapse¹
• Optimized bioavailability¹
• Xcellent safety and tolerability profile³
• Increased confidence with efficacy²
  - works for both Gram (-) and Gram (+) bacteria²
  - works even for atypical pathogens²
  
  References:
  1. Finished Product Certificate of Analysis. MSN Laboratories Pvt Ltd. AR No: FP2203052; SpecNo. RPS-TM01-001-03.
  2. WHO updated guidelines for drug-resistant tuberculosis (2016).
  3. Certificate of Analysis. Center of Excellence in Drug Research, Evaluation and Studies Inc. C.A No: 22-M-1117. Date of Issuance 07/03/2023
  
  

4th Floor, 393 Goodwill Bldg.,
Senator Gil Puyat Avenue,
Brgy. Bel-Air, Makati City

Related MIMS Drugs

FLOXSAFE/FLOXSAFE IV